RE: RNS!10 Dec 2021 07:23
the latest biomarker data that will help identify patients who will benefit from Bexmarilimab treatment. This will potentially increase the likelihood of a positive future pivotal trial.
Its just takes time and I think most thought we would be over £10 by now,